STEVENS CAPITAL MANAGEMENT LP - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q2 2014$158,000
+6.8%
16,305
-7.0%
0.00%0.0%
Q4 2013$148,000–17,523–0.00%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders